MAM
Mastrapasqua Asset Management’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $2.48M | Sell |
12,654
-55
| -0.4% | -$10.8K | 0.29% | 67 |
|
2023
Q2 | $2.67M | Sell |
12,709
-12
| -0.1% | -$2.52K | 0.3% | 67 |
|
2023
Q1 | $2.57M | Sell |
12,721
-916
| -7% | -$185K | 0.32% | 67 |
|
2022
Q4 | $2.97M | Sell |
13,637
-197
| -1% | -$42.9K | 0.39% | 64 |
|
2022
Q3 | $2.72M | Buy |
13,834
+201
| +1% | +$39.6K | 0.39% | 68 |
|
2022
Q2 | $2.92M | Sell |
13,633
-709
| -5% | -$152K | 0.4% | 69 |
|
2022
Q1 | $4.07M | Sell |
14,342
-742
| -5% | -$211K | 0.46% | 63 |
|
2021
Q4 | $5.68M | Sell |
15,084
-497
| -3% | -$187K | 0.56% | 55 |
|
2021
Q3 | $6.43M | Sell |
15,581
-215
| -1% | -$88.7K | 0.7% | 48 |
|
2021
Q2 | $5.84M | Buy |
15,796
+422
| +3% | +$156K | 0.62% | 53 |
|
2021
Q1 | $4.46M | Buy |
15,374
+2,661
| +21% | +$771K | 0.52% | 59 |
|
2020
Q4 | $3.18M | Sell |
12,713
-727
| -5% | -$182K | 0.42% | 64 |
|
2020
Q3 | $3.04M | Sell |
13,440
-134
| -1% | -$30.3K | 0.43% | 64 |
|
2020
Q2 | $2.37M | Buy |
13,574
+49
| +0.4% | +$8.54K | 0.36% | 68 |
|
2020
Q1 | $1.71M | Sell |
13,525
-175
| -1% | -$22.1K | 0.33% | 65 |
|
2019
Q4 | $2.09M | Buy |
13,700
+180
| +1% | +$27.5K | 0.34% | 75 |
|
2019
Q3 | $1.79M | Buy |
13,520
+85
| +0.6% | +$11.3K | 0.33% | 74 |
|
2019
Q2 | $1.91M | Buy |
13,435
+10
| +0.1% | +$1.42K | 0.36% | 74 |
|
2019
Q1 | $1.95M | Sell |
13,425
-10
| -0.1% | -$1.45K | 0.37% | 76 |
|
2018
Q4 | $1.52M | Buy |
13,435
+255
| +2% | +$28.9K | 0.34% | 75 |
|
2018
Q3 | $1.77M | Sell |
13,180
-160
| -1% | -$21.5K | 0.34% | 74 |
|
2018
Q2 | $1.5M | Buy |
13,340
+4,440
| +50% | +$499K | 0.3% | 82 |
|
2018
Q1 | $950K | Buy |
8,900
+835
| +10% | +$89.1K | 0.19% | 98 |
|
2017
Q4 | $883K | Sell |
8,065
-550
| -6% | -$60.2K | 0.18% | 100 |
|
2017
Q3 | $931K | Buy |
+8,615
| New | +$931K | 0.19% | 95 |
|